N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma

BACKGROUND: TRAF3, a new tumor suppressor identified in human non-Hodgkin lymphoma (NHL) and multiple myeloma (MM), induces PKCδ nuclear translocation in B cells. The present study aimed to evaluate the therapeutic potential of two PKCδ activators, N-Benzyladriamycin-14-valerate (AD 198) and ingenol...

Descripción completa

Detalles Bibliográficos
Autores principales: Edwards, Shanique K E, Moore, Carissa R, Liu, Yan, Grewal, Sukhdeep, Covey, Lori R, Xie, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853153/
https://www.ncbi.nlm.nih.gov/pubmed/24131623
http://dx.doi.org/10.1186/1471-2407-13-481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853153/
https://www.ncbi.nlm.nih.gov/pubmed/24131623
http://dx.doi.org/10.1186/1471-2407-13-481

Ejemplares similares